Beata M.
- Country
- Poland
- Department
- N/A
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study
Data & Insights
Has run more than one trial at 276 of 404 partner sites.
Specializations
Inflammatory Bowel Disease
Clinical research activity is centered on ulcerative colitis and Crohn’s disease, with additional involvement in broader inflammatory bowel disease care. The portfolio reflects interest in therapies aimed at controlling intestinal inflammation, improving remission, and supporting long-term disease management.
- Ulcerative colitis
- Crohn’s disease
- Endoscopic response
- Clinical remission
Work in this area includes therapeutic evaluation across both maintenance and long-term treatment settings for chronic gastrointestinal inflammation.
Cardiovascular Disease
Research interests extend to cardiovascular disease, with a strong focus on atrial fibrillation, myocardial infarction, heart failure, and arterial hypertension. The clinical landscape also includes atherosclerotic cardiovascular disease and related risk reduction strategies.
- Atrial fibrillation
- Heart failure
- Myocardial infarction
- Arterial hypertension
This area also covers therapies for post-infarction cardiac dysfunction, blood pressure control, and prevention of recurrent cardiovascular events.
Metabolic Disease and Weight Management
The investigator is involved in studies addressing obesity, overweight, mixed dyslipidemia, and chronic weight management. This includes therapeutic interest in cardiometabolic risk, body weight reduction, and metabolic complications linked to excess adiposity.
- Obesity
- Overweight
- Mixed dyslipidemia
- Chronic weight management
Related work includes interventions relevant to cardiometabolic health in patients with coexisting cardiovascular disease.
Allergic, Urticarial, and Respiratory Conditions
Another therapeutic focus is chronic urticaria, including chronic spontaneous urticaria, chronic inducible urticaria, cold-induced urticaria, and symptomatic dermographism. The portfolio also includes asthma, chronic obstructive pulmonary disease, and other inflammatory lung disease conditions.
- Chronic spontaneous urticaria
- Chronic inducible urticaria
- Cold-induced urticaria
- Inflammatory lung disease
These studies reflect interest in symptom control, provocation response, and treatment options for immune-mediated skin and airway disorders.
Gastroesophageal and Other Immune-Mediated Disorders
Additional clinical involvement includes erosive esophagitis due to gastroesophageal reflux disease, immune system diseases, and early Alzheimer’s disease with biomarkers of inflammation. The portfolio also reaches into selected cardiometabolic and inflammatory conditions linked to systemic disease burden.
- Erosive esophagitis
- Gastroesophageal reflux disease
- Immune system diseases
- Early Alzheimer’s disease
This area shows engagement with therapeutic approaches spanning digestive, immune-mediated, and inflammation-associated disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.